Author:
Horti Andrew G.,Raymont Vanessa,Terry Garth E.
Publisher
Springer Berlin Heidelberg
Reference333 articles.
1. Addy C, Wright H, Van Laere K et al (2008) The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake. Cell Metab 7:68–78
2. Ahmad R, Evens N, Koole M et al (2011) Whole-body biodistribution and radiation dosimetry of the human cannabinoid type-2 receptor ligand [11C]-NE40 in healthy subjects. J Nucl Med 52(Suppl 1):1470
3. Ahn K, Smith SE, Liimatta MB et al (2011) Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain. J Pharmacol Exp Ther 338:114–124
4. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE et al (2003) P-glycoprotein: from genomics to mechanism. Oncogene 22:7468–7485
5. Anand P, Whiteside G, Fowler CJ et al (2009) Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain Res Rev 60:255–266
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献